Biotechnology in Austria

Jungbunzlauer

Jungbunzlauer is a leading producer of high-quality, sustainable ingredients from natural sources, serving industries from food and beverage, to nutrition, health, home and personal care, among others. Leading the way in developing naturally better ingredients that enhance everyday life, we are a trusted partner offering a diverse portfolio of texturants, acidulants, sweeteners, minerals, and tailored solutions to meet our customers’ evolving needs. Headquartered in Basel, Switzerland, with state-of-the-art facilities including large-scale fermentation operations across Europe and North America, we proudly serve more than 130 countries worldwide. Founded more than 150 years ago, Jungbunzlauer has grown into a CHF 1.3 billion company, driven by nearly 1,400 dedicated colleagues committed to a healthier, more sustainable future. See our community guidelines here:

1001 to 5000 staff

Marinomed Biotech Ag

Marinomed Biotech AG is an Austrian, science-driven biotech company with a growing development pipeline and globally marketed therapeutics. The Company focuses on the development of innovative, patent-protected products in the therapeutic areas of respiratory and ophthalmic diseases, based on the proprietary Marinosolv® platform. The Marinosolv® technology significantly improves the solubility and bioavailability of hardly soluble compounds, enabling the development of novel therapies for immune-related and inflammatory disorders. Under the brand Solv4U Marinomed offers drug development in all stages, based on its patent protected Marinosolv® technology platform. The Company’s Carragelose®-based OTC business was successfully sold to Unither Pharmaceuticals in 2025 Headquartered in Korneuburg, Austria, Marinomed is listed on the standard market of the Vienna Stock Exchange (VSE:MARI).

11 to 50 staff

Sarcura

Cell therapy has transformed cancer treatment, yet the hurdles of manufacturing patient-derived cell therapies remain a formidable challenge for the industry. Quality and scalability problems lead to high therapeutic costs and limit access to those life-saving treatments. By harnessing the power of cutting-edge semiconductor technologies, including silicon photonics seamlessly integrated into microfluidic cartridges, Sarcura is orchestrating a transformative shift. Central to Sarcura's mission is the creation of fully automated manufacturing systems endowed with real-time process and product control. This pioneering platform promises to usher in a new era of cost-effective and secure cell therapies, democratizing access to these critical treatments. We aim for a 100x production boost and 10x cost reduction, driving the industrialization of cell therapy manufacturing. Delve deeper at where the future of cancer treatment is being reshaped.

11 to 50 staff

University Of Natural Resources And Life Sciences, Vienna

The University of Natural Resources and Life Sciences, Vienna, the Alma Mater Viridis, sees itself as an education and research centre for renewable resources, which are a necessity for human life. With its wide range of areas of expertise it is the task of BOKU to contribute significantly to the protection of life resources for future generations. With a connection between natural sciences, engineering and economics, BOKU is trying to deepen the knowledge of an ecologically and economically sustainable use of natural resources in a cultivated landscape. The interaction between man, society and the environment forms the basis of all activities at the BOKU, and its foremost aim is to make decisive contributions to securing the well-being of future generations. In this endeavour, it will seek ways of ensuring a sustainable and environmentally sound management of natural resources by allying the competences of the natural, engineering, economic and social sciences. In support of its leading role in teaching and research at an international level, the following are considered to be of special significance: • Natural resources and their management • Food, nutrition and health • The natural and man-made environment • Living space and quality of life Topics in Teaching and Research - sustainable use of naturally growing raw materials both for energy supply as well as for innovative materials protecting regenerable sources such as water, soil, and atmosphere shaping true to life recycling processes interrelation between food production and health protecting and shaping biotopes and environments protecting the wellbeing of plants, animals, and humans

1001 to 5000 staff

Dna4me Gmbh

Just like all of us have different tastes and preferences, we all have different genetic needs. With a simple saliva sample you can gain invaluable information about your body and learn how your genes influence your immune system, your weight, your wellbeing and even your skincare. We critically investigate your results and communicate key insights in a comprehensible report so you can focus on responding to your body's needs - with uniquely personalised skincare, nutritional supplements and tailored exercise programmes.

1 to 10 staff

Lifetaq-Analytics Gmbh

LifeTaq accelerates drug discovery and development by addressing critical bottlenecks in preclinical research. We provide the automation technology that meets the demands of today while enabling the life science lab of the future. Built upon years of specialized knowledge in automation, our modular machine platforms offer superior process control, helping the biotech, pharmaceutical, CRO, and academic sectors to: • Reduce manual work and variability. • Improve reproducibility across in vitro experiments. • Accelerate research outcomes. We ensure qualitatively superior culturing conditions by providing precise, automated control media change and critical incubation parameters. This superior culture quality is continuously validated via integrated, machine-based quality measurements that assess cell and tissue viability and integrity in real time.

1 to 10 staff

Mybios

Protein-based molecules provide unique physical and biochemical characteristics and are biodegradable. Our mission is to provide solutions to produce proteins and enzymes. We build on the yeast Pichia pastoris, which is known for secretion and high yields. We have established an independent toolbox for protein production. Our inducible methanol-free system builds on inducible promoters, non-toxic inducers and engineered strains.

1 to 10 staff

Pharm-Analyt - Bioanalysis

BIOANALYSIS Assay development, validation and implementation (HPLC-MS/MS, UV and Fluorescence) determining analytes in complex matrices (plasma, urine, tissue) during preclinical, clinical phases and discovery phase. GLP and GMP certified. QUANTIFICATION (in Plasma, Urine, Tissue)- Small Molecules (f.i. 250 fg/mL in plasma)- Peptides (up to 10 kDa)- PEG (Polyethylene glycol)- Polymers like PEI and Polyoxazolines - Polysaccharides IDENTIFICATION Structure Elucidation of Unknown Peaks- Metabolite Profiling - Impurities & Degradation Products - Side & Byproducts INVESTIGATION - Bioanalytical Feasibilities (2-4 days)- Tissue Analysis - Enantioselective Separation in Plasma - Trouble Shooting BIOMARKERS Discovery of Biomarkers in Plasma - Small Molecules - Peptides Several Patents (Orphan Diseases) EQUIPMENT: LTQ Orbitrap XL (Thermo Scientific) HPLC-MS/MS QTRAP 6500 SelexION (AB Sciex) HPLC-MS/MS Xevo TQ-XS (Waters) As well as conventional detectors like ELSD.

11 to 50 staff

Sinsoma Gmbh

Wir sind Expert:innen für DNA-Analytik. Mit über 25 Jahren Erfahrung in der Entwicklung und Anwendung von DNA-Methoden bieten wir Ihnen präzise und zuverlässige Lösungen. Wir sind europaweit tätig und treiben die DNA-Analytik in den Bereichen Umwelt, Gesundheit und Lebensmittel voran. Unsere treibenden Kräfte sind: die Welt ein Stückchen verbessern, Umwelt verstehen, Biodiversität erfassen und Gesundheit erhalten. Der Begriff „Sinsoma” leitet sich von den beiden Teilen „Sine” und „Soma” ab, die im Lateinischen „ohne” bzw. „Körper” bedeuten. Das „Sinsoma“-Verfahren ermöglicht den Nachweis von Organismen, ohne dass Tiere gefangen oder Blumen gepflückt werden müssen. Als Spin-off der Universität Innsbruck sind wir an der Schnittstelle zwischen Forschung und Anwendung tätig. Unser Labor ist mit modernsten Geräten ausgestattet. Eine lückenlose Dokumentation und regelmäßige Qualitätssicherung garantieren Sicherheit und Zufriedenheit.

11 to 50 staff

Valanx Biotech

Partner with us and leverage our technology for the development of the next wave of superior protein conjugates and Antibody-Drug-Conjugates! Looking to fast track your development of next generation bioconjugates, staying ahead of your competitors? With the complete freedom to choose where on the protein, we conjugate and optimize for: • Stability, • Aggregation, • Superior efficacy, • Therapeutic window. and more! The process is simple! Get in touch with us (message us here or visit our website). After you let us know about your protein of interest, we produce different site-specific conjugate versions for you. They are shipped either to you or your CRO. You collect the data you need. Go or no-go decision.

11 to 50 staff

Econutri

We specialize in producing sustainable proteins through the fermentation of organisms that can efficiently utilize CO₂, helping to reduce our carbon footprint and promote a healthier planet. Our impact goes beyond sustainable protein production. By utilizing CO2 and green hydrogen to create high-quality proteins, we’re helping to reduce greenhouse gas emissions, decrease land usage for agriculture, and conserve natural resources. Get in touch with us if you want to find out more about the project!

1 to 10 staff

Cebina - Central European Biotech Incubator And Accelerator

At CEBINA (Central European Biotech Incubator and Accelerator), we go beyond a traditional biotechnology incubator - uniquely supporting life science entrepreneurs and young biotech companies through all stages of early company development, transforming promising new ideas into fully formed biotech companies that are attractive for investment.

11 to 50 staff

Calyxha Biotechnologies

Calyxha is a private biotech company developing novel small molecule anti-inflammatory drugs.

1 to 10 staff

Greenclean.Group

Green Cleaning Revolution Gesund & ökologisch sauber! Die greenclean-group bietet einen wertvollen Beitrag die eigene Gesundheit sowie das Ökosystem der Erde effektiv zu schützen und gleichzeitig mit modernster Technik für noch nie dagewesene Hygiene und Sauberkeit in allen Bereichen zu sorgen! Ohne Chemie und Plastikmüll - ein Leben lang!

1 to 10 staff

Current Research In Biotechnology

Excellence paves the way

1 to 10 staff

Bdi-Biolife Science

1 Astaxantin Producer from Austria

11 to 50 staff

Celheal

Beauty is a reflection of good health and good health comes with CelHeal.purity you deserve. CelHeal's mission is sustainable product innovation through the creation of new, high-performance cell-wall polysaccharide molecules employing biocatalysts. Utilizing our in vitro/in vivo/in silico screening-enabled molecular design platform, we discover, develop, and manufacture cell-wall polysaccharides that unlock previously inaccessible functionalities. Our high-quality actives are derived from natural sources and produced using biotechnology, enhancing both safety and efficacy in cosmetic formulations while promoting environmentally friendly practices. Our first ingredient, NovaGx, is a highly pure sugar-based product showing unique biological activities, specifically designed for premium personal care formulations. Join us on this exciting journey to transform the world of healthcare and beauty with CelHeal.purity you deserve.

1 to 10 staff

Sciencendeavors

SciencEndeavors (SE) is a privately held business development company. SE specializes in growing things by working with clients to create business; financial; marketing and communication plans. SE has vast experience in turning science ideas into commercially viable entities. The owner, Dr. Scot Wallace, MBA has over 14 years of experience in sciences + business sector.

1 to 10 staff

Brauerei Schwechat Ag

1 to 10 staff

Olerup

Olerup is global distributor of molecular diagnostic products and services for HLA typing and antibody detection. We act through Olerup GmbH, with office in Vienna, Austria, and Olerup Inc, with office in West Chester, PA, USA. On April 14, 2016, Olerup was acquired by CareDx, Inc.(Nasdaq: CDNA) and the company is now a subsidiary of CareDx. To learn more about CareDx, please visit

11 to 50 staff

Tikopia Consulting

1 to 10 staff

Dsm Austria Gmbh Former Erber Group

DSM Austria GmbH was founded in 2021 after Royal DSM acquired the former ERBER Group, consisting of its subsidiaries BIOMIN and Romer Labs, in October 2020. DSM Austria’s specialty animal nutrition and health business Biomin specializes primarily in mycotoxin risk management and gut health performance management. The Romer Labs business focuses on food and feed safety diagnostic solutions. The acquisition has further strengthened DSM’s position as the world market leader in mycotoxin risk management (toxins produced by molds) and as a leading provider of sustainable feed and animal health solutions. With its head office in Getzersdorf and production and research facilities based in Tulln, DSM Austria is perfectly placed as a central hub for feed additives and premixes in DSM’s global network. ERBER Group companies:

1001 to 5000 staff

Holloid

Real-time bioprocess and hygiene monitoring with automated high-throughput 3D microscopy

11 to 50 staff

Affiris Ag

We are a clinical-stage biotechnology company that strives to challenge established treatment options for neurodegenerative diseases in order to preserve the quality of life of patients. WE FOCUS ON UNMET MEDICAL NEEDS IN CHRONIC DISEASES Currently available treatments for many neurodegenerative diseases aim to manage symptoms, and do not stop disease progression. As a result, neurodegenerative diseases often lead to a reduced quality of life. Better treatments for these diseases are needed to give patients healthier, happier, and longer lives. We aim to develop therapeutic and preventative treatments that address the root causes of neurodegenerative diseases: an ethos inspired by the impact of vaccines on health and society worldwide. OUR APPROACH Our novel approach, Specific Active ImmunoTherapy (SAIT), stimulates the body’s own immune system to find and fight proteins central to the development and progression of neurodegenerative diseases. SAIT was developed using our AFFITOME technology, which allows for optimization of immune responses against pathogenic forms of proteins, and it may permit targeting of multiple pathogenic proteins in one disease setting. SAIT is designed to induce a long-lasting immune response, which we anticipate will translate into effective quarterly/twice-yearly dosing. OUR PIPELINE We have a broad portfolio of immunotherapy candidates, which are currently in clinical trials or preclinical development for chronic diseases, including Parkinson’s Disease, multiple system atrophy (MSA), dementia with Lewy bodies (DLB), and Huntington's disease. OUR TEAM We are a passionate and dedicated team with a proven track record of making ground-breaking scientific discoveries and developing novel therapies. Our exciting work spans early discovery, preclinical advancement of SAIT and monoclonal antibody drug candidates, and translation of science into clinical development. Please follow us on LinkedIn and visit

11 to 50 staff